Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Gastric Cancer Management and Outcomes, Metastasis and carcinoma case studies, Esophageal Cancer Research and Treatment, and Gastrointestinal Tumor Research and Treatment.
Atezolizumab and Trastuzumab Plus Chemotherapy for <i>ERBB2</i>-Positive Locally Advanced Resectable Gastric Cancer
2118P Perioperative sintilimab plus oxaliplatin and S-1 (SOX) versus SOX alone in resectable locally advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC): A multicenter randomized phase II study (PERSIST)
Chinese expert consensus on diagnosis and treatment of small gastrointestinal stromal tumors (2025 edition)
Atezolizumab and trastuzumab plus chemotherapy in patients with HER2+ locally advanced resectable gastric cancer or adenocarcinoma of the gastroesophageal junction: A multicenter, randomized, open-label phase II study.
Unveiling prognosis and traits of dMMR/MSI-H gastric and colorectal cancer after curative surgery: A large-scale, multi-center, retrospective study in China.
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
Intraperitoneal Chemotherapy Using Fluorouracil Implants Combined With Radical Resection and Postoperative Adjuvant Chemotherapy for Stage III Gastric Cancer: A Multi-Center, Randomized, Open-Label, Controlled Clinical Study
Clinicopathologic Characteristics and Prognosis of <i>PDGFRA</i>-Mutant Gastrointestinal Stromal Tumors: A Large-Scale, Multi-Institutional, Observational Study in China
Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system
PIAS3, an inhibitor of STAT3, has intensively negative association with the survival of gastric cancer.
PubMed 2015cited by 15position: last